Biotalys
VUB

Biotalys

Biotech
Biotech
Biotech
Biotech

Biotalys is developing a new generation of protein-based biocontrol solutions. Euronext: BTLS.

Biotalys develops innovative formulations of crop protection products based on Agrobodies (antibody fragments from camel antibodies). These products can be used at lower dosages or have a longer lasting effect without repeat applications and thereby contribute to improved and more sustainable agricultural production. The company is a spin-off of the Vrije Universiteit Brussel and VIB.

No items found.
Marc Zabeau

Marc Zabeau

Managing Partner Qbic I

This company is aligned with the following SDGs

No items found.
MRM Health
Qbic II
Biotech
Biotech
Biotech
Biotech

MRM Health

MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.

Universiteit Gent
moveUP
Qbic II
HealthTech
HealthTech
HealthTech
HealthTech

moveUP

moveUP develops personalized remote digital care for patients undergoing surgery and other interventions.

AZ Maria Middelares
VUB
THERAtRAME
Qbic III
Biotech
Biotech
Biotech
Biotech

THERAtRAME

THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.

ULiège